We used logistic regression models to analyse the four week and long term continuous abstinence rates with additional terms for baseline salivary cotinine concentration or baseline modified Fagerström test score and their interaction with treatment.
Four weeks after long term but not short term challenges, percentages of IFN-γ producing lung cells (5.31±0.45%) were significantly elevated compared to long term PBS controls (3.64±0.55%, p<0.01, n = 10, 2 independent experiments).
Further, the percentage of IL-5 producing lung cells were significantly elevated following OVA challenges compared to PBS challenged controls and IL-5 producing lung cells were significantly more common three days and two weeks after long term OVA challenges (5.43±0.72% and 5.78±0.36%, p<0.01, n = 10) than after short term exposure (3.76±0.44% and 3.28±0.29%, both n = 10).
Currently, pupils get six to seven weeks off in the summer, with two weeks at each of Christmas and Easter as well as three week-long half-term breaks.
Main outcome measures The primary outcome at short term (eight weeks) and long term (one year) follow-up was the Zurich Claudication Questionnaire score.
Or, to express that figure in another way, she slept with a new man every other day, those terms being just eight weeks long.
Erythema score One trial (Attarzadeh 2013) compared short-term (up to four weeks) and long-term treatments with clotrimazole versus steroid treatments.
For dichotomous outcomes such as the proportion of participants with lack of clearance of symptoms, we expressed the estimate of effect as a risk ratio (RR) with 95% confidence interval (Cl) at both short-term follow-up (up to four weeks) and long-term follow-up (more than four weeks).
The Independent Activities Period is a four-week-long "term" offering hundreds of optional classes, lectures, demonstrations, and other activities throughout the month of January between the Fall and Spring semesters.
Follow-up was classified as short term (up to two weeks), intermediate (two weeks to three months), and long term (more than three months).
A 38-week long-term relapse prevention trial with three phases.
